Myristoyl-Lys-Arg-Thr-Leu-Arg-OH

Modify Date: 2024-01-02 15:17:40

Myristoyl-Lys-Arg-Thr-Leu-Arg-OH structure	Common Name	Myristoyl-Lys-Arg-Thr-Leu-Arg-OH
	CAS Number	125678-68-4	Molecular Weight	883.17600
	Density	1.26g/cm3	Boiling Point	N/A
	Molecular Formula	C₄₂H₈₂N₁₂O₈	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Myristoyl-Lys-Arg-Thr-Leu-Arg-OH

N-Myristoyl-Lys-Arg-Thr-Leu-Arg is a protein kinase C (PKC) inhibitor with an IC50 value of 75 μM. N-Myristoyl-Lys-Arg-Thr-Leu-Arg inhibits IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat[1].

Name	(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-6-amino-2-(tetradecanoylamino)hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid
Synonym	More Synonyms

Description	N-Myristoyl-Lys-Arg-Thr-Leu-Arg is a protein kinase C (PKC) inhibitor with an IC50 value of 75 μM. N-Myristoyl-Lys-Arg-Thr-Leu-Arg inhibits IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat[1].
Related Catalog	Signaling Pathways >> Epigenetics >> PKC Research Areas >> Inflammation/Immunology Signaling Pathways >> TGF-beta/Smad >> PKC
In Vitro	N-Myristoyl-Lys-Arg-Thr-Leu-Arg (0-50 μM) inhibits the production and release of IL-2 from cultured Jurkat cells stimulated with TPA plus either PHA or OKT3 mAb[1].